Nektar Therapeutics is headquartered in San Francisco and participated in a conference in New York City on September 4, 2025.
3 reports, 1 independent
Updated Jul 28
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Nektar Therapeutics is headquartered in San Francisco and participated in a conference in New York City on September 4, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Nektar Therapeutics confirmed its San Francisco headquarters and attended a conference in NYC.1 source
Nektar Therapeutics, based in San Francisco, is active on LinkedIn.1 source
Keep exploring
The entities involved
-
Nektar Therapeutics
American healthcare company
Nothing else this week.
Related events
- Nektar Therapeutics is seeking FDA review for its late-stage drug trials.
- Multiple financial firms, including KBC Group NV, WINTON GROUP Ltd, and Deutsche Bank, increased their stakes in Nektar Therapeutics on September 12, 2026.
- Nathan Miller is associated with an investigation involving Nektar Therapeutics.
Coverage
Newest first; wire copies grouped- PR NewswireNektar Therapeutics to Participate in Two Investor Conferences in September SAN FRANCISCO, Sept. 3, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be we
- PR NewswireNektar to Announce Financial Results for the Second Quarter on Thursday, August 7, 2025, After Close of U.S.-Based Financial Markets SAN FRANCISCO, July 31, 2025 /PRNewswire/ -- Nektar Therapeutics (